Howard Lee - 10 Jun 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
10 Jun 2022
Transactions value $
$0
Form type
4
Filing time
14 Jun 2022, 17:28:03 UTC
Previous filing
07 Jun 2022
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Award $0 +4,163 +3% $0 142,939 10 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Award $0 +10,984 $0 10,984 10 Jun 2022 Common Stock 10,984 $30.02 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 10, 2023.
F2 All of the shares subject to the option vest on June 10, 2023.